191 related articles for article (PubMed ID: 16379000)
1. Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.
Guerra S; López-Fernández LA; Pascual-Montano A; Nájera JL; Zaballos A; Esteban M
J Virol; 2006 Jan; 80(2):985-98. PubMed ID: 16379000
[TBL] [Abstract][Full Text] [Related]
2. Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.
Guerra S; Nájera JL; González JM; López-Fernández LA; Climent N; Gatell JM; Gallart T; Esteban M
J Virol; 2007 Aug; 81(16):8707-21. PubMed ID: 17537851
[TBL] [Abstract][Full Text] [Related]
3. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2017 May; 91(9):. PubMed ID: 28179536
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.
Delaloye J; Filali-Mouhim A; Cameron MJ; Haddad EK; Harari A; Goulet JP; Gomez CE; Perdiguero B; Esteban M; Pantaleo G; Roger T; Sékaly RP; Calandra T
J Virol; 2015 Apr; 89(7):3819-32. PubMed ID: 25609807
[TBL] [Abstract][Full Text] [Related]
5. Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells.
Guerra S; López-Fernández LA; Conde R; Pascual-Montano A; Harshman K; Esteban M
J Virol; 2004 Jun; 78(11):5820-34. PubMed ID: 15140980
[TBL] [Abstract][Full Text] [Related]
6. Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.
Nájera JL; Gómez CE; García-Arriaza J; Sorzano CO; Esteban M
PLoS One; 2010 Jun; 5(6):e11406. PubMed ID: 20613977
[TBL] [Abstract][Full Text] [Related]
7. Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.
Nájera JL; Gómez CE; Domingo-Gil E; Gherardi MM; Esteban M
J Virol; 2006 Jun; 80(12):6033-47. PubMed ID: 16731942
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
[TBL] [Abstract][Full Text] [Related]
9. The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation.
Shisler JL; Jin XL
J Virol; 2004 Apr; 78(7):3553-60. PubMed ID: 15016878
[TBL] [Abstract][Full Text] [Related]
10. NYVAC: a highly attenuated strain of vaccinia virus.
Tartaglia J; Perkus ME; Taylor J; Norton EK; Audonnet JC; Cox WI; Davis SW; van der Hoeven J; Meignier B; Riviere M
Virology; 1992 May; 188(1):217-32. PubMed ID: 1566575
[TBL] [Abstract][Full Text] [Related]
11. Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response.
Di Pilato M; Mejías-Pérez E; Sorzano COS; Esteban M
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424281
[TBL] [Abstract][Full Text] [Related]
12. Human gene profiling in response to the active protein kinase, interferon-induced serine/threonine protein kinase (PKR), in infected cells. Involvement of the transcription factor ATF-3 IN PKR-induced apoptosis.
Guerra S; López-Fernández LA; García MA; Zaballos A; Esteban M
J Biol Chem; 2006 Jul; 281(27):18734-45. PubMed ID: 16613840
[TBL] [Abstract][Full Text] [Related]
13. NYVAC vector modified by C7L viral gene insertion improves T cell immune responses and effectiveness against leishmaniasis.
Sánchez-Sampedro L; Mejías-Pérez E; S Sorzano CÓ; Nájera JL; Esteban M
Virus Res; 2016 Jul; 220():1-11. PubMed ID: 27036935
[TBL] [Abstract][Full Text] [Related]
14. Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.
Quakkelaar ED; Redeker A; Haddad EK; Harari A; McCaughey SM; Duhen T; Filali-Mouhim A; Goulet JP; Loof NM; Ossendorp F; Perdiguero B; Heinen P; Gomez CE; Kibler KV; Koelle DM; Sékaly RP; Sallusto F; Lanzavecchia A; Pantaleo G; Esteban M; Tartaglia J; Jacobs BL; Melief CJ
PLoS One; 2011 Feb; 6(2):e16819. PubMed ID: 21347234
[TBL] [Abstract][Full Text] [Related]
15. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines.
Welter J; Taylor J; Tartaglia J; Paoletti E; Stephensen CB
J Virol; 2000 Jul; 74(14):6358-67. PubMed ID: 10864646
[TBL] [Abstract][Full Text] [Related]
16. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.
Paoletti E; Taylor J; Meignier B; Meric C; Tartaglia J
Dev Biol Stand; 1995; 84():159-63. PubMed ID: 7796949
[TBL] [Abstract][Full Text] [Related]
17. Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways.
Gómez CE; Perdiguero B; Sánchez-Corzo C; Sorzano COS; Esteban M
Viruses; 2017 Dec; 10(1):. PubMed ID: 29280955
[TBL] [Abstract][Full Text] [Related]
18. Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus.
O'Donnell SM; Holm GH; Pierce JM; Tian B; Watson MJ; Chari RS; Ballard DW; Brasier AR; Dermody TS
J Virol; 2006 Feb; 80(3):1077-86. PubMed ID: 16414985
[TBL] [Abstract][Full Text] [Related]
19. Expression of different NF-kappaB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling.
Baltathakis I; Alcantara O; Boldt DH
J Cell Biochem; 2001 Aug 1-9; 83(2):281-90. PubMed ID: 11573245
[TBL] [Abstract][Full Text] [Related]
20. Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.
Willis KL; Langland JO; Shisler JL
J Biol Chem; 2011 Mar; 286(10):7765-7778. PubMed ID: 21183678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
